COARE Biotechnology Inc - Company Review
COARE Biotechnology Inc - Company ReviewSummary
COARE Biotechnology Inc (COARE Biotechnology) is a drug development company that focuses on the development of therapeutic agents for eradication of cancer stem cells and metastases. It designs therapeutic drugs to treat solid tumor cancers. The company’s pipeline portfolio offers drug candidiates, namely, CBT-15mAB, CBT-3112 ADC, CBT-311 NP and DCLK1 Kinase Inhibitors for the treatment of pancreatic, colorectal, breast and renal cancers. It also develops drug candidates in the fields of immunotherapy and nanomedicine. The company has discovered a protein that influences the growth of cancer stem cells and they are trying to develop therapeutics for blocking the protein that will inhibit the growth of tumor. COARE Biotechnology is headquartered in Oklahoma City, Oklahoma, the US.
This comprehensive company report of COARE Biotechnology Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.